Literature DB >> 7172407

Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for response.

J F Stewart, J L Hayward, R D Rubens, R J King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7172407     DOI： 10.1007/bf00265394

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  8 in total

1.  Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.

Authors:  R D Rubens; R J King; S Sexton; M J Minton; J L Hayward
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  The lack of relationship between estrogen receptor status and response to chemotherapy.

Authors:  R Hilf; M L Feldstein; E D Savlov; S L Gibson; B Seneca
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

3.  The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.

Authors:  M E Lippman; J C Allegra; E B Thompson; R Simon; A Barlock; L Green; K K Huff; H M Do; S C Aitken; R Warren
Journal:  N Engl J Med       Date:  1978-06-01       Impact factor: 91.245

4.  Steroid hormone receptors and clinical usefulness in human breast cancer.

Authors:  Y Nomura; J Yamagata; K Takenaka; H Tashiro
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

5.  Estrogen receptor status and response to chemotherapy in advanced breast cancer.

Authors:  D T Kiang; D H Frenning; J Gay; A I Goldman; B J Kennedy
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer.

Authors:  G Bonadonna; P Valagussa; G Tancini; G Di Fronzo
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.

Authors:  C Fabian; L Sternson; M Barnett
Journal:  Cancer Treat Rep       Date:  1980 Jun-Jul

8.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  8 in total
  2 in total

1.  The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.

Authors:  I Mitchell; N Deshpande; R Millis; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.

Authors:  J R Masters; R S Camplejohn; R R Millis; R D Rubens
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.